These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1092907

  • 41. [State of the liver in middle-aged and elderly patients with pulmonary tuberculosis under prolonged chemotherapy].
    Iashchenko BP, Iakimets VP.
    Vrach Delo; 1971 Oct; 10():86-90. PubMed ID: 5142544
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917
    [No Abstract] [Full Text] [Related]

  • 44. [Effects of morphazinamide administered alone or in association in treatment of pulmonary tuberculosis. Observations on 126 treated cases].
    Longarato FJ.
    Minerva Med; 1965 Sep 05; 56(71):2954-61. PubMed ID: 5322284
    [No Abstract] [Full Text] [Related]

  • 45. [Results of a shortened (6 months) schedule of treatment of pulmonary tuberculosis using INH, RMP and PZA].
    Szymański A, Czaplińska-Jóźwiak E.
    Pneumonol Pol; 1987 Jun 05; 55(6):241-5. PubMed ID: 3317292
    [No Abstract] [Full Text] [Related]

  • 46. [Candidiasis as a complication of antibacterial therapy in pulmonary tuberculosis].
    Kovalenko LG.
    Probl Tuberk; 1965 Jun 05; 43(5):28-33. PubMed ID: 5858235
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb 05; 59(2):81-9. PubMed ID: 6379258
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Side effects of ethambutol treatment of patients with chronic destructive pulmonary tuberculosis].
    Adamovich VN, Reĭderman IB, Vyrenkova TE, Chelnokova NV.
    Probl Tuberk; 1973 Feb 05; 51(10):33-6. PubMed ID: 4784034
    [No Abstract] [Full Text] [Related]

  • 56. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV.
    Probl Tuberk; 1968 Feb 05; 46(8):43-7. PubMed ID: 5709113
    [No Abstract] [Full Text] [Related]

  • 57. [Therapeutic effects of lividomycin in the retreatment for pulmonary tuberculosis patients].
    Yamamoto M, Fukuhara T, Aoyagi T.
    Kekkaku; 1973 Apr 05; 48(4):121-7. PubMed ID: 4721804
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Treatment of tuberculosis in persons with mental diseases].
    Shcherbatiuk AS, Sabanov AI.
    Probl Tuberk; 1980 Jan 05; (1):48-51. PubMed ID: 7367424
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.